Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11456491rdf:typepubmed:Citationlld:pubmed
pubmed-article:11456491lifeskim:mentionsumls-concept:C0028630lld:lifeskim
pubmed-article:11456491lifeskim:mentionsumls-concept:C0243041lld:lifeskim
pubmed-article:11456491lifeskim:mentionsumls-concept:C0059040lld:lifeskim
pubmed-article:11456491lifeskim:mentionsumls-concept:C0037628lld:lifeskim
pubmed-article:11456491lifeskim:mentionsumls-concept:C1551336lld:lifeskim
pubmed-article:11456491pubmed:issue29lld:pubmed
pubmed-article:11456491pubmed:dateCreated2001-7-17lld:pubmed
pubmed-article:11456491pubmed:abstractTextSeveral elongation factor (EF) Tu mutants (T25A, H22Y/T25S, D80N, D138N) that have impaired nucleotide binding show decreased solubility on overexpression in the E. coli cell, an indication that they do not fold correctly. Moreover, EF-Tu[T25A] and EF-Tu[D80N] were shown to inhibit cell growth on expression, an effect attributed to their sequestration of EF-Ts [Krab, I. M., and Parmeggiani, A. (1999) J. Biol. Chem. 274, 11132--11138; Krab, I. M., and Parmeggiani, A. (1999) Biochemistry 38, 13035--13041]. We present here results showing that the co-overexpression of EF-Ts at a 1:1 ratio dramatically improves the solubility of mutant EF-Tu, although in the case of EF-Tu[D138N]--which cannot at all bind the nucleotides available in the cell--this is a slow process. Moreover, with co-overexpression of EF-Ts, the mentioned growth inhibition is relieved. We conclude that for the formation of a correct EF-Tu structure the nucleotide plays an important role as a "folding nucleus", and also that in its absence EF-Ts can act as a folding template or steric chaperone for the correct folding of EF-Tu.lld:pubmed
pubmed-article:11456491pubmed:languageenglld:pubmed
pubmed-article:11456491pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11456491pubmed:citationSubsetIMlld:pubmed
pubmed-article:11456491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11456491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11456491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11456491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11456491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11456491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11456491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11456491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11456491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11456491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11456491pubmed:statusMEDLINElld:pubmed
pubmed-article:11456491pubmed:monthJullld:pubmed
pubmed-article:11456491pubmed:issn0006-2960lld:pubmed
pubmed-article:11456491pubmed:authorpubmed-author:ParmeggianiAAlld:pubmed
pubmed-article:11456491pubmed:authorpubmed-author:BernardiAAlld:pubmed
pubmed-article:11456491pubmed:authorpubmed-author:KrabI MIMlld:pubmed
pubmed-article:11456491pubmed:authorpubmed-author:te...lld:pubmed
pubmed-article:11456491pubmed:issnTypePrintlld:pubmed
pubmed-article:11456491pubmed:day24lld:pubmed
pubmed-article:11456491pubmed:volume40lld:pubmed
pubmed-article:11456491pubmed:ownerNLMlld:pubmed
pubmed-article:11456491pubmed:authorsCompleteYlld:pubmed
pubmed-article:11456491pubmed:pagination8531-5lld:pubmed
pubmed-article:11456491pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11456491pubmed:meshHeadingpubmed-meshheading:11456491...lld:pubmed
pubmed-article:11456491pubmed:meshHeadingpubmed-meshheading:11456491...lld:pubmed
pubmed-article:11456491pubmed:meshHeadingpubmed-meshheading:11456491...lld:pubmed
pubmed-article:11456491pubmed:meshHeadingpubmed-meshheading:11456491...lld:pubmed
pubmed-article:11456491pubmed:meshHeadingpubmed-meshheading:11456491...lld:pubmed
pubmed-article:11456491pubmed:meshHeadingpubmed-meshheading:11456491...lld:pubmed
pubmed-article:11456491pubmed:meshHeadingpubmed-meshheading:11456491...lld:pubmed
pubmed-article:11456491pubmed:meshHeadingpubmed-meshheading:11456491...lld:pubmed
pubmed-article:11456491pubmed:meshHeadingpubmed-meshheading:11456491...lld:pubmed
pubmed-article:11456491pubmed:meshHeadingpubmed-meshheading:11456491...lld:pubmed
pubmed-article:11456491pubmed:meshHeadingpubmed-meshheading:11456491...lld:pubmed
pubmed-article:11456491pubmed:meshHeadingpubmed-meshheading:11456491...lld:pubmed
pubmed-article:11456491pubmed:meshHeadingpubmed-meshheading:11456491...lld:pubmed
pubmed-article:11456491pubmed:meshHeadingpubmed-meshheading:11456491...lld:pubmed
pubmed-article:11456491pubmed:year2001lld:pubmed
pubmed-article:11456491pubmed:articleTitleElongation factor Ts can act as a steric chaperone by increasing the solubility of nucleotide binding-impaired elongation factor-Tu.lld:pubmed
pubmed-article:11456491pubmed:affiliationGroupe de Biophysique-Equipe 2, Ecole Polytechnique, F-91128 Palaiseau Cedex, France.lld:pubmed
pubmed-article:11456491pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11456491pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:944866entrezgene:pubmedpubmed-article:11456491lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11456491lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11456491lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11456491lld:pubmed